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a b s t r a c t
As avian inﬂuenza A(H5N1) viruses continue to circulate in Asia and Africa, global concerns of an
imminent pandemic persist. Recent experimental studies suggest that efﬁcient transmission between
humans of current H5N1 viruses only requires a few genetic changes. An essential step is alteration of the
virus hemagglutinin from preferential binding to avian receptors for the recognition of human receptors
present in the upper airway. We have identiﬁed receptor-binding changes which emerged during
H5N1 infection of humans, due to single amino acid substitutions, Ala134Val and Ile151Phe, in the
hemagglutinin. Detailed biological, receptor-binding, and structural analyses revealed reduced binding of
the mutated viruses to avian-like receptors, but without commensurate increased binding to the human-
like receptors investigated, possibly reﬂecting a receptor-binding phenotype intermediate in adaptation
to more human-like characteristics. These observations emphasize that evolution in nature of avian
H5N1 viruses to efﬁcient binding of human receptors is a complex multistep process.
& 2013 The Authors. Published by Elsevier Inc.
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2013.08.010
0042-6822 & 2013 The Authors. Published by Elsevier Inc.
n Corresponding author at: Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
nn Corresponding author. Tel.: +44 (0)20-7594 7207.
E-mail addresses: dejongmd@gmail.com (M.D. de Jong), t.feizi@imperial.ac.uk (T. Feizi).
1 Present address: Research Unit in Pediatric Vaccines, Galician Genetics Group, Hospital Clínico Universitario de Santiago de Compostela, Spain.
2 These authors contributed equally.
3 Present address: MOA Key Laboratory of Plant Pathology, China Agricultural University, No. 2 Yuanmingyuan Xilu, Beijing, PR China.
4 Present address: MRC Technology, 1–3 Burtonhole Lane, London NW7 1AD, United Kingdom.
5 Present address: Xiang Ya Second Afﬁliated Hospital, Central South University, PR China.
Virology 447 (2013) 326–337
Open access under CC BY license.
Open access under CC BY license.
Introduction
Since 1997, highly pathogenic avian inﬂuenza A(H5N1) viruses
have spread among poultry and wild birds in Asia, the Middle-
East, Europe and Africa and caused over 600 reported human
infections in 15 countries with a case-fatality ratio of approxi-
mately 60% (WHO, 2012). Sporadic human infections continue to
occur in countries where A(H5N1) viruses have become endemic
in birds, providing a persistent threat to global health due to the
possibility of virus adaptation towards efﬁcient transmission
among humans and ensuing pandemic spread. Recent evidence
from experiments with ferrets, a widely accepted animal model for
inﬂuenza in humans, suggest that only a limited number of genetic
changes is needed for airborne transmission of H5N1 viruses
(Imai et al., 2012; Herfst et al., 2012). Thus, monitoring of genetic
changes, especially during human infections, and studying the
relevance of such changes for human adaptation remains essential.
The molecular mechanisms that allow avian inﬂuenza viruses to
cross the species barrier from birds to humans are incompletely
understood. However, a prerequisite for efﬁcient transmission
of avian viruses between humans is a change from preferential
recognition by the virus hemagglutinin (HA) of α2-3-sialyl-
galactose-terminating host cell receptors, predominant in avian
respiratory and gastrointestinal epithelia, to those terminating in
α2-6-sialyl-galactose, which predominate in the human upper
respiratory tract (Rogers and Paulson, 1983; Rogers and D'Souza,
1989). Accordingly, HAs of the 20th century pandemic viruses (H1N1
in 1918, H2N2 in 1957 and H3N2 in 1968) evolved from their original
recognition of avian α2-3-sialyl- to preferential α2-6-sialyl-receptor
binding (Connor et al., 1994; Matrosovich et al., 2000; Glaser et al.,
2005; Stevens et al., 2006b; Tumpey et al., 2007). Thus to better
understand the nature and signiﬁcance of such adaptive changes, it
is essential to monitor HA changes that may affect receptor speciﬁ-
city of avian inﬂuenza viruses, particularly during human infection.
In this study, we screened receptor-binding preferences of
thirty H5N1 viruses, isolated in MDCK cells, from poultry and
humans in Vietnam during 2004 and 2005, by comparing hemag-
glutination patterns using horse and guinea pig red blood cells
(RBCs), which differ in sialic acid receptor distribution (Ito et al.,
1997b; Medeiros et al., 2001). We detected patterns indicative of
changes in receptor speciﬁcity in three human H5N1 isolates. Our
analyses of these viruses and their egg-passaged counterparts
indicated a rapid emergence of adaptive receptor-binding variants
of H5N1 virus, and also demonstrated that marked discrepancies
can occur in quasispecies distributions between clinical specimens
and cell culture- or egg-grown viruses, thus emphasizing the need
for genetic monitoring directly in clinical specimens.
Results
Agglutination of horse RBCs
To screen for the receptor-binding preferences of avian and
human inﬂuenza H5N1 viruses isolated in MDCK cells, we com-
pared the relative agglutination of horse RBCs, which express
predominantly α2-3-sialyl sequences (Ito et al., 1997a) and guinea
pig RBCs, which express both α2-3- and α2-6-sialyl sequences
(Medeiros et al., 2001). As predicted, seasonal human H1N1 and
H3N2 inﬂuenza A viruses (n¼10) did not agglutinate horse RBCs,
whereas avian inﬂuenza viruses (n¼15; H5N1, H4N6, H6N1) iso-
lated from poultry agglutinated efﬁciently both horse and guinea
pig RBCs (Table 1). Out of 11 inﬂuenza H5N1 viruses isolated from
upper respiratory tract specimens of humans, eight agglutinated
efﬁciently both types of RBCs, similar to poultry viruses. However,
two of the human H5N1 virus isolates (A/Vietnam/CL1/2004 and
A/Vietnam/CL105/2005) resembled seasonal human inﬂuenza A
viruses and did not agglutinate horse RBCs (Table 1). A third isolate
(A/Vietnam/CL2009C/2005) showed a 15-fold lower hemagglutina-
tion titer with horse RBCs than with guinea pig RBCs (Table 1 and
Supplementary Table S1). These results suggested that three of the 11
human H5N1 viruses had reduced binding to α2-3-sialyl receptors.
We investigated whether the hemagglutination properties
of these three human H5N1 viruses would ‘revert’ to efﬁcient
horse RBC agglutination when replicating in the presence of
predominantly α2-3-sialyl receptors. Indeed, after passaging the
viruses ﬁve times in the allantois of embryonated chicken eggs,
which contain only α2-3-sialyl receptors (Ito et al., 1997b), all
three viruses (re)gained efﬁcient agglutination of horse RBCs
(Table 1). Passage in eggs did not, however, alter the agglutination
patterns of other avian inﬂuenza viruses isolated from humans or
poultry or seasonal human inﬂuenza viruses (Table 1). Plaque
assays showed that the MDCK cell isolate and egg passaged variant
of A/Vietnam/CL1/2004 and A/Vietnam/CL105/2005 exhibited
similar growth characteristics in MDCK cells.
Amino acid changes in HA
To identify amino acid changes in HA associated with the
hemagglutination patterns of A/Vietnam/CL1/2004, A/Vietnam/
CL105/2005, and A/Vietnam/CL2009C/2005, the sequences of HA1
of the MDCK cell isolates were compared with those following
passage in eggs. A single amino acid difference was observed in
the HA of each egg-grown virus (Table 2): Asp186Glu in A/Vietnam/
CL1/2004, Val134Ala in A/Vietnam/CL105/2005, and Phe151Leu in
A/Vietnam/CL2009C/2005 (H5 numbering). Changes in the ﬁrst two
viruses represented reversions to the avian H5 consensus sequence
following egg passage. The consensus residue at position 151 is
Ile rather than Leu. Interestingly, sequence analysis in the original
clinical specimen revealed a subpopulation of 151Ile and not Leu
(see below).
Quasispecies distributions in clinical specimens and virus isolates
To determine whether the sequences in the MDCK cell isolates
were representative of those present during the human infection
Table 1
Hemagglutination titers of MDCK cell- and egg-cultured Inﬂuenza A viruses.
Virus Subtype Origin MDCK GMTa ω5 GMTa
Horse Guinea pig Horse Guinea pig
A/VN/HTD33/04 H1N1 Human 0 75 0 24
A/VN/HTD34/04 H1N1 Human 0 192 0 32
A/VN/HTD566/04 H3N2 Human 0 53 0 4
A/VN/HTD567/04 H3N2 Human 0 21 0 8
A/Ck/VLC13/06 H5N1 Chicken 267 144 12 32
A/Ck/VLC15/06 H5N1 Chicken 491 416 64 24
A/Dk/LAD404/06 H4N6 Duck 341 352 48 128
A/Dk/DTD516/06 H6N1 Duck 224 160 32 32
A/VN/CL1/04 H5N1 Human 0 100 512 192
A/VN/CL2/04 H5N1 Human 52 72 64 48
A/VNCL26/04 H5N1 Human 64 192 256 192
A/VN/CL36/04 H5N1 Human 64 68 64 64
A/VN/PEV016/04 H5N1 Human 32 44 128 96
A/VN/CL100/05 H5N1 Human 112 352 192 384
A/VN/CL105/05 H5N1 Human 0 120 128 320
A/VN/CL107/05 H5N1 Human 112 464 NAb NAb
A/VN/CL115/05 H5N1 Human 112 200 8 20
A/VN/CL119/05 H5N1 Human 80 136 384 384
A/VN/CL2009C/05 H5N1 Human 27 405 128 96
ω5: ﬁve serial passages in the allantois of embryonated hen eggs.
a Geometric mean titers of triplicates.
b Not analyzed due to technical difﬁculties.
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and to analyze quasispecies populations, pyrosequencing speciﬁ-
cally targeting HA positions 134, 186 and 151 was performed
directly on clinical specimens as well as on the viruses cultured in
MDCK cells and eggs (Table 2). These analyses conﬁrmed the
presence of Asp186 in the MDCK cell isolate of A/Vietnam/CL1/
2004 and the reversion to Glu186 after egg passage. Surprisingly,
direct pyrosequencing of viruses in clinical specimens from the
nose and throat of the patient showed the presence of only
Glu186, indicating that the Asp186 variant had emerged during
passage in MDCK cells, but not during infection of respiratory
epithelium of the patient.
Pyrosequencing also conﬁrmed the predominance of the
Phe151 variant(s) of A/Vietnam/CL2009C/2005 in the MDCK cell
isolate which changed to Leu151 after egg passage. A throat
specimen obtained from the patient, after 7 days of illness,
contained 65% of the Phe151 variant, which increased to 100% in
a sequential sample taken at day 8, at the time the specimen was
taken for virus isolation in MDCK cells. Interestingly, the remain-
ing 35% of virus quasispecies in the ﬁrst specimen contained Ile at
position 151, which represents the consensus residue at this
position of the avian H5 sequence, and not Leu as observed in
egg-passaged virus. Of note, a virus isolated in MDCK cells from a
respiratory swab 5 days after the onset of illness in the same
patient (A/Vietnam/CL2009/2005) had the consensus sequence
with Ile151 (GenBank accession number DQ497729) (Tran et al.,
2004; Beigel et al., 2005; de Jong et al., 2005b, 2006), indicating
that the major virus population during earlier stages of infection
had not mutated.
The MDCK cell isolate A/Vietnam/CL105/2005 consisted of a
mixed virus population with similar proportions of Ala134 and
Val134 variants, whereas the egg-cultured virus contained pre-
dominantly the Ala134 variant. In the original clinical specimen,
obtained after 4 days of illness, Val134 variants predominated in
the virus population at 74%.
Recombinant viruses
To compare the effects of the observed amino acid changes on
receptor binding, two sets of recombinant viruses, which contain
an H5 gene together with seven PR8 genes, were constructed
using reverse genetics (Table 3). In one set (rVN1194-like) single
amino acid substitutions, corresponding to the residues altered
during egg passage, were introduced into the HA of the parental
‘wild type’ recombinant A/Vietnam/1194/2004 virus (NIBRG14,
rVN1194). In the second set of viruses additional substitutions
were introduced, by mutagenesis or chemical synthesis, such that
the HA sequences were identical to those of the corresponding
MDCK cell isolates (Table 3). The agglutination patterns of the
recombinant viruses with Val134 or Asp186 were comparable to
those of the corresponding MDCK cell isolates (Tables 1 and 3).
Attempts to recover viruses possessing Phe151 in HA, in a PR8
genetic background, for receptor binding studies were unsuccess-
ful as passage in MDCK (as well as MDCK-SIAT1) cells resulted in
mixed Phe151/Leu151 populations, whereas Leu151 was selected
during passage in eggs. For crystallographic studies, HA of the
Phe151 variant was produced using a vaccinia virus construct.
Table 3
Amino acid differences and hemagglutination patterns with guinea pig and horse
red blood cells of recombinant H5N1 virusesa.
Viruses HA residue number Hemagglutination
titerb
83 94 134 175 186 188 Guinea pig Horse
NIBRG14 (rVN1194) Ala Asp Ala Leu Glu Thr 256 128
rVNCL105 (Ala134Val) Val Val Val Ile Ile 256 4
rVN1194 (Ala134Val) Val 1024 o4
rVNCL01 (Glu186Asp) Met Asp 1024 o4
rVN1194 (Glu186Asp) Asp 512 o4
a The residue designation is according to H5 numbering. Differences from the
sequence of VN1194 are shown. Amino acids in positions that were altered on egg
passage are highlighted in bold.
b Using the virus-containing allantoic ﬂuid before puriﬁcation of the viruses for
the microarray analyses.
Fig. 1. Binding of biotinylated sialylglycopolymers 3SLN-PAA (30 kDa) and 6SLN-
PAA (1 MDa) to viruses adsorbed in 96-well microplates. H5N1 viruses rVN1194
(circles), rVN1194(Ala134Val) (diamonds), rVNCL105(Ala134Val) (ﬁlled diamonds),
rVN1194(Glu186Asp) (triangles), rVNCL01(Glu186Asp) (ﬁlled triangles). Control
human H3N2 virus R1 (asterisks). The data show averaged values of two replicates
and are representative of two independent experiments performed on
different days.
Table 2
Amino acid residues in MDCK cell- and egg-cultured viruses and viruses in clinical
specimens.
Virus isolates and clinical
samples (day since
onset of illness)
HA position Amino acid (%)a
Wild-typeb Mutant
A/VN/CL1/04 186 Glu (5) Asp (95)
A/VN/CL1/04 ω5 186 Glu (97) Asp (3)
CL1 Throat swab (d8)c 186 Glu (100) Asp (0)
CL1 Nose swab (d10) 186 Glu (100) Asp (0)
A/VN/CL2009C/05 151 Ile (3) Phe (95), Leu (2)
A/VN/CL2009C/05 ω5 151 Ile (0) Phe (2), Leu (98)
CL2009 Throat swab (d7) 151 Ile (35) Phe (65)
CL2009 Nose swab (d8) 151 Ile (0) Phe (100)
CL2009 Throat swab (d8)c 151 Ile (0) Phe (100)
A/VN/CL105/05 134 Ala (48) Val (52)
A/VN/CL105/05 ω5 134 Ala (96) Val (4)
CL105 Throat swab (d4)c 134 Ala (26) Val (74)
CL105 Tracheal aspirate (d4) 134 Ala (27) Val (73)
ω5: ﬁve serial passages in the allantois of embryonated chicken eggs.
a Proportions of subpopulations were determined by pyrosequencing of the
regions of interest.
b Wild-type refers to the avian virus consensus sequence.
c Source of the MDCK cell isolate.
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Binding to soluble sialylglycopolymers
The effects of the mutations were analyzed by assaying the
binding of soluble sialylglycopolymers (SGPs) to immobilized
viruses. Initially, the low molecular mass (30 kDa) SGPs, α2-3-
sialyl-N-acetyllactosamine (3SLN)-PAA and α2-6-sialyl-N-acetyl-
lactosamine (6SLN)-PAA were used. There was strong binding of
the 3SLN-PAA to the ‘wild type’ rVN1194, whereas binding to the
four recombinant H5N1 viruses with mutations at positions 134 or
186 was signiﬁcantly less avid. There was no detectable binding of
this SGP to a human H3N2 virus R1, used as a control (Fig. 1). The
low molecular mass 6SLN-PAA gave no binding to any of the H5N1
viruses, although there was binding to the human H3N2 virus
R1 (data not shown). To increase the sensitivity of detection of
binding of the viruses to the α2-6-sialyl sequence, we used the
high molecular mass (1 MDa) 6SLN-PAA that has higher glycan
valency. This SGP bound to the two recombinant viruses with a
Glu186Asp mutation, although signiﬁcantly less strongly than to
the control human H3N2 virus R1 (Fig. 1); ‘wild type’ rVN1194 and
the two recombinant Ala134Val mutants were not bound.
Analysis of binding speciﬁcity by biolayer interferometry
Receptor binding of the recombinant H5N1 viruses rVN1194,
rVN1194(Glu186Asp) and rVN1194(Ala134Val) was analyzed by
biolayer interferometry using the biotinylated SGPs 3SLN-PAA and
6SLN-PAA immobilized on streptavidin-coated biosensors. Equili-
brium binding measurements were recorded at varying sugar
immobilization densities at a constant virus concentration. The
three viruses showed binding to 3SLN (Fig. 2). In this assay format,
the rVN1194(Glu186Asp) mutant virus bound with a slightly lower
afﬁnity (approximately 5-fold lower) to the 3SLN than did the
‘wild type’ rVN1194 virus, whereas the rVN1194(Ala134Val)
mutant virus bound with much lower (approximately 20-fold)
afﬁnity. The rVN1194(Ala134Val) mutant, like the rVN1194 virus,
showed no detectable binding to 6SLN. In contrast, the rVN1194
(Glu186Asp) mutant showed detectable binding to 6SLN; this was,
however, approximately 50-fold weaker than to the 3SLN.
Patterns of oligosaccharide binding in carbohydrate microarray
analyses
To gain insights into oligosaccharide binding speciﬁcities of the
ﬁve recombinant H5N1 viruses, we performed carbohydrate
microarray analyses using a diverse range of sialylated oligosac-
charide sequences (Childs et al., 2009; Liu et al., 2010). All ﬁve
recombinant H5N1 viruses bound to numerous α2-3-sialyl
sequences (Fig. 3, Supplementary Table S2). In accord with data
from the other two types of SGP-binding assays, the two 134
mutant viruses, rVNCL105(Ala134Val) and rVN1194(Ala134Val),
showed markedly lower intensities of binding to the α2-3-sialyl
sequences compared with the ‘wild type’ rVN1194 virus, and
without any detectable binding to the α2-6-sialyl sequences
included in the microarray (Fig. 3). The 186 mutants differed from
the ‘wild type’ and the 134 mutants in their ability to bind to α2-6-
sialyl sequences. Interestingly, in the microarray analyses, whereby
the oligosaccharide probes are presented in a highly clustered
state on the solid surface, no reduction was apparent in binding
intensities to the α2-3-sialyl sequences by the 186 mutants
compared with the ‘wild type’ virus. The reassortant human
H3N2 virus, X31, included as an example of virus with HA well-
adapted to humans showed, as predicted, preferential binding to
α2-6- over α2-3-sialyl sequences.
The four mutant H5N1 viruses resembled the rVN1194 virus
in showing high relative binding to the α2-3-sialyl bi-
antennary N-glycan (probe ♯61). The multi-antennary α2-3-
sialyl N-glycans with or without poly-N-acetyllactosamine
extensions were also bound with varying intensities
(♯62–♯65). To assist close comparisons of the binding intensities
of the ﬁve recombinant H5N1 viruses and X31, results are
presented in Table 4 for 24 of the sialyl probes that are well
matched with respect to backbone sequences, substituents, and
aglycones. The 134 mutant viruses showed little or no binding
to the α2-3-sialyl sequences, di- and tetra-saccharides of the
lacto (type I) or neolacto (type II) series, that lacked fucosyla-
tion or sulphation (♯23, ♯25, ♯39, ♯40 and ♯41), whereas the 186
mutants resembled the rVN1194 virus in giving binding signals
with these probes. Binding signals were diminished with
fucosylation at the penultimate N-acetylglucosamine (GlcNAc)
of type I (♯26 vs. ♯23; ♯47 vs. ♯39/LSTa) and type II sequences
(♯27 vs. ♯25/3SLN; ♯58 vs. ♯59). On the other hand, probes with
sulphation at the penultimate GlcNAc, as on the trisulphated
keratan sulfate (♯46) and fucosylated 6-sulpho-sialyl-Lewis x
(Lex) (♯55), elicited binding with all ﬁve H5N1 viruses. Inter-
estingly, the presence of another acidic residue, α2-6-linked
sialic acid, at the penultimate GlcNAc also elicited relatively
strong binding intensities with ‘wild type’ and mutant viruses
(♯107 vs. ♯39). In contrast, sulphation at the terminal galactose,
as in the sulphated sialyl-Lex (♯53 and ♯57) elicited binding only
with the 186 mutants. The preference of ‘wild type’ and mutant
H5N1 viruses for α2-3-sialyl glycans with sulfate or sialic acid
on the 6 position of the penultimate GlcNAc residue and their
reduced binding to glycans that are fucosylated at this residue
is in agreement with ﬁndings from previous microarray studies
with recombinant HAs of A/Vietnam/1203/2004 (Stevens et al.,
2006a) and the H5 consensus sequence (Gambaryan et al.,
2004; Wang et al., 2009).
The binding of the two 186 mutants to the biantennary α2-6-
sialyl N-glycan (probe ♯98) was less intense than to the α2-3-sialyl
analog (♯61), in contrast to X-31. Moreover, the 186 mutants
showed little or no binding to many of the α2-6-sialyl sequences
bound by X-31, including the trisaccharide probe 6SLN (♯87) and the
pentasaccharide probe LSTc (♯90). In contrast to the rVN1194 virus,
the 186 mutants, exhibited binding to α2-8-polysialyl sequences
(♯122 and ♯123), although this was weaker than that of X31.
Fig. 2. Virus binding analysis by biolayer interferometry. H5 viruses rVN1194
(circles), rVN1194(Glu186Asp) (triangles) and rVN1194(Ala134Val) (diamonds)
were analyzed for binding to immobilized biotinylated 30 kDA sialylglycopolymers
3SLN-PAA and 6SLN-PAA.
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In sum, the salient changes observed in the microarray analyses
were: ﬁrst, an overall decrease of α2-3-sialyl binding by the
134 mutants compared with the ‘wild type’ virus while retaining
binding to bi- and multiantennary α2-3-sialyl N-glycans and
6-sulphated sequences, but without any detectable α2-6-sialyl
binding; and second, the binding of the 186 mutants to the
bi-antennary α2-6-sialyl N-glycan but without any apparent
reduction in binding to α2-3-sialyl sequences.
Crystallographic studies
The effects of the single amino acid substitutions in the HA on
receptor binding were also studied by X-ray crystallography of HAs
in complex with pentasaccharides possessing terminal sialic acid
(Sia) linked to galactose (Gal) by either α2-3 (LSTa) or α2-6 (LSTc)
linkage.
In the wild type H5 HA complex with the avian receptor analog
LSTa, the ﬁrst three residues, Sia-1, Gal-2, GlcNAc-3 were detected
(Ha et al., 2001) but in the Glu186Asp complex only Sia-1 and
Gal-2 could be seen (Fig. 4A). This suggests lower afﬁnity of the
186 mutant for the α2-3 sequence. In the wild type HA, Glu186
forms a H-bond with the 9-OH of Sia-1 (Ha et al., 2001). The
carboxylate of Asp186 in the mutant is not as close to the 9-OH
and as a consequence, the interaction is less tight. The complexes
of wild type and Glu186Asp mutant HAs with LSTc showed similar
features and indicate only weak binding (Fig. 4B). In both struc-
tures, there was clear electron density for only Sia-1, the
2-6-linkage atoms, and two or three additional atoms of Gal-2.
Introduction of a more bulky Val134 side-chain in the mutant,
in place of the highly conserved Ala134 in wild type HA, increases
the width of the hydrophobic channel between the 130- and 220-
loops that form the front and left edges of the receptor-binding
site (Fig. 4C). As a consequence, the H-bond between Gln222 and
Ser132 is not formed in the mutant. The distances between Gln222
and the glycosidic-linkage O and between Gln222 and the 4-OH of
Gal-2 are also slightly increased; as a consequence, the H-bonds
formed between Gln222 and LSTa are weaker and Gal-2 was not
readily discernible. In the Ala134Val mutant–LSTc complex, only
Sia-1 was detected, suggesting slightly weaker binding of the
human receptor analog (LSTc), than to the wild type HA (Fig. 4D).
Fig. 3. Carbohydrate microarray analyses of wild type and mutant H5N1 viruses and X31(H3N2) as control. Numerical scores for the binding signals are shown as means of
duplicate spots at 5 fmol/spot (with error bars) and are representative of at least three independent experiments. The insets show enlarged the Y-axis scales for the 134
mutant viruses, which gave very low binding signals. The microarrays consisted of lipid-linked oligosaccharide probes, printed on nitrocellulose-coated glass slides. These
are listed in Supplementary Table S2 and arranged according to sialic acid linkage and oligosaccharide backbone sequence. The various types of sialic acid linkage are
indicated by the colored panels as deﬁned at the bottom of the ﬁgure.
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Table 4
Virus binding to 24 oligosaccharide probes that are well matched with respect to backbone sequences, substituents and aglycones in the carbohydrate microarrays.
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These observations are consistent with the comparative binding
data obtained with the wild type H5 and the Glu186Asp and
Ala134Val mutant recombinant viruses.
Sialic acid was not detected in crystals of the Ile151Phe mutant
HA soaked in either LSTa or LSTc receptor analogs. Comparison of
the wild type and mutant HAs indicates that the side-chain of
Phe151 projects into the receptor binding site about 2 Å further
than Ile151 (Fig. 4E). This may restrict receptor binding and
consequently impair virus replication.
Discussion
Changes in the receptor binding characteristics were detected
in three of eleven MDCK cell-grown viruses, isolated from upper
respiratory tract specimens of inﬂuenza H5N1 infected patients,
and none of 13H5N1 viruses isolated from poultry. Single amino
acid substitutions responsible for the receptor binding changes
were identiﬁed. Two of the substitutions, Ala134Val and Ile151Phe,
were also observed in sequences in the clinical samples from
which the isolates were derived, albeit in differing proportions of
virus quasispecies compared to MDCK cell isolates, and were
therefore likely selected during human infection. In contrast, the
Glu186Asp substitution was not detected in the sequence of the
clinical specimen and therefore most likely emerged during
isolation in MDCK cells, although the presence in the clinical
specimen of a minority population below the detection limit of the
pyrosequencing method and subsequent selection in cell culture
cannot be ruled out.
These observations indicate that H5N1 variants with changing
patterns of receptor recognition may rapidly emerge during
human H5N1 infections and that further selection of variants in
culture systems occurs which may obscure actual evolutionary
events during human infection. Precise insights into the effects of
observed HA substitutions on receptor recognition are essential to
fully understand the evolutionary pathways towards human
adaptation of H5N1 viruses, which we addressed using several
approaches.
Detailed analyses of the binding properties of the recombinant
viruses containing the Ala134Val substitution, observed in virus
isolated from a fatal case of H5N1 infection after 4 days of illness,
showed consistently that binding to α2-3-sialyl sequences was
reduced, but with no detectable increase in binding to the
repertoire of α2-6-sialyl sequences examined. The dominant effect
of the single 134 substitution was conﬁrmed by the similarity in
the binding proﬁles of the virus with the single substitution and of
the virus with the additional 4 substitutions corresponding to the
sequence of the MDCK cell isolate. Proportions of 134Val variants
were higher in the clinical specimens when compared to the
virus isolate (74% vs. 52%), suggesting some reversion to wild-
type sequence during culture in α2,3 sialyl-receptor containing
MDCK cells. Repeated identiﬁcation of the Ala134Val substitution
in clade 1 human H5N1 isolates (Auewarakul et al., 2007; Li et al.,
2004), but not in contemporary clade 1 viruses isolated from
birds, emphasizes its potential signiﬁcance in human infection.
A previous report identiﬁed the presence of two HA mutations,
Ala134Val plus Leu129Val in H5N1 virus from another fatal case
in Thailand, which resulted in reduced binding to α2-3-sialyl
receptors, but also increased binding to α2-6-sialyl receptors
(Auewarakul et al., 2007). Although the Leu129Val substitution
alone did not alter the relative binding to the two types of
receptor, the effect of the single Ala134Val substitution without
the Leu129Val was not described in that report. Tang et al. (2012)
recently reported that an Ala134Val substitution in the HA, of a
H5N1 isolate from a fatal case in Cambodia, was responsible for
reduced binding of HA to MDCK cells and a reduced capacity to
agglutinate horse RBCs. In the present instance, no evidence was
obtained regarding the possibility that other mutations in HA or
other genes within the mixed virus population might complement
the properties of the single 134 mutant.
The crystallographic structure of the HA–receptor complexes
provided an explanation for the poor receptor binding by the
Ala134Val mutant HA, namely that distortion of the binding site by
the bulkier valine residue would potentially cause a reduction in
the strength of H-bonds between receptor and binding site. The
consequent increased width of the site is more akin to that of
human H3 (and H9) viruses with their preference for α2-6-sialyl
receptors. Whether such changes to the binding site result in
improved binding to natural receptors cannot be assessed in the
absence of more detailed information as to their identity.
The emergence of the Ile151Phe variant was observed between
days 5 and 8 of illness in a patient who ultimately succumbed to
infection with an oseltamivir-resistant virus (Tran et al., 2004). The
151Phe variant comprised 65% of the virus population on day 7,
increasing to 100% in the clinical specimen from which the MDCK
cell isolate was derived on day 8. Unfortunately, recombinant virus
containing this substitution could not be propagated in either
MDCK cells or eggs, preventing comparable receptor binding
analyses. Soaking crystals of the Ile151Phe HA, prepared by
vaccinia virus expression, with either the α2-3- or α2-6-sialyl
pentasaccharide failed to yield any evidence of ligand binding. The
structure of the mutant HA shows that the larger Phe side chain
projects further into the binding site such that it may restrict
binding. It would appear that this mutation is only advantageous
in the presence of compensatory mutations in HA or other genes.
In this respect, the possible role of other HA substitutions in this
virus relative to VN1194 HA, including Ser133Ala, Leu175Met and
Thr188Ala, deserves further research. No other instance of an
Ile151Phe substitution in the HA of H5N1 viruses has been
reported. However, substitution at this position by threonine
(the residue present in human H3 viruses) has been observed in
a number of human and avian clade 2.2 viruses isolated between
2004 and 2008, and has become a common feature of a subclade
(B1) of Egyptian clade 2.2.1 avian and human viruses since 2009.
Although the single Ile151Thr substitution did not affect receptor
binding, it was observed to act synergistically with a deletion in
residue 129 (also typical of this sublineage) to increase α2-6-sialyl
binding (Watanabe et al., 2011).
The Glu186Asp substitution, observed in an MDCK cell-grown
virus (but not in the clinical specimen) isolated from a patient who
survived the infection, did not markedly alter binding of virus to
α2-3-sialyl receptors, in terms of the intensity and spectrum of
sequences bound, in the microarray analyses where the oligosac-
charide probes are presented in a clustered state, or to immobi-
lized 3SLN-PAA by biolayer interferometry. However, in the third
assay procedure with sialoglycopolymer binding to immobilized
virus, the Glu186Asp substitution caused a considerable reduction
in binding of the low molecular weight trisaccharide 3SLN poly-
mer. This is consistent with poor resolution of the α2-3-sialyl
tetrasaccharide, LSTa, in crystals of the HA(Glu186Asp)–LSTa com-
plex. These assay systems using soluble low molecular weight
sialoglycopolymer binding to ‘immobilized’ HA thus appear more
sensitive in detecting a decrease in afﬁnity for α2-3-sialyl glycans.
A signiﬁcant change relative to the ‘wild-type’ virus was
observed in the binding of the Glu186Asp mutants to α2-6-sialyl
sequences in all three types of binding assay. Binding was,
however, still less intense than to α2-3-sialyl analogs and rela-
tively poor compared to that of the human H3 virus X31. This was
also reﬂected by the poor resolution of moieties other than the
terminal sialic acid in the HA(Glu186Asp)–LSTc complex.
Glu186 is highly conserved, with no substitutions detected
among avian or human H5N1 viruses except A/Vietnam/CL1/
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2004. While the presence of an undetectable minority population
cannot be excluded, the absence of 186Asp variants in the clinical
specimen as measured by pyrosequencing, strongly suggests that
this substitution emerged during MDCK cell culture and illustrates
the differences in selective pressures encountered in vitro and
in vivo. At any rate, our observations indicate that α2-6-sialyl
binding H5N1 variants can emerge during replication in mamma-
lian cells containing these receptors.
The reduction in binding of α2-3-sialyl sequences by the
Ala134Val mutant and indication of the same for the Ile151Phe
and Glu186Asp mutants is consistent with their loss of ability to
agglutinate horse RBCs, which was readily restored on reversion of
the mutation on passage (in an avian environment) in eggs. In
contrast, there was little discernible effect on agglutination of
guinea pig RBCs by the Ala134Val substitution despite weak
binding to the α2-6-sialyl sequences included in this study.
Fig. 4. Crystal structures of wild type and mutant H5 hemagglutinins complexed with avian and human receptor analogs (LSTa and LSTc, respectively). (A) Superposition of
complexes of LSTa with rVN1194 HA (gray) and with rVN1194(Glu186Asp) HA (green). (B) Superposition of complexes of LSTc with rVN1194 HA (gray) and with rVN1194
(Glu186Asp) HA (green). Only density for the Sia-1 of the receptor analog was detected. (C) Superposition of complexes of LSTa with rVN1194 HA (gray) and with rVN1194
(Ala134Val) HA (yellow). The increase in width of the hydrophobic channel between the 130 and 220 loops in the mutant that results in an increase in the distance between
Gln222 and Ser132 is shown. (D) Superposition of complexes of LSTc with rVN1194 HA (gray) and with rVN1194(Ala134Val) HA (yellow). Only density for the Sia-1 of the
receptor analog was detected. E, Superposition of the complex of rVN1194 HA with LSTc (gray) and rVN1194(Ile151Phe) HA (blue). Although no sialic acid was detected in the
Ile151Phe crystals soaked in LSTc the proximity of Phe 151 to where the sialic acid would be located is shown.
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Although these features suggest speciﬁc adaptive evolutionary
events in vivo, the signiﬁcance of the selection of such a pheno-
type, with reduced binding to avian receptors in the absence of
increased preference for human receptors, is not immediately
apparent. The microarray encompasses a considerable repertoire
of α2-6-sialyl sequences; however, there may be other ‘human-
type’ receptor sequences in the respiratory tract that are recog-
nized by the mutant hemagglutinins. Alternatively, the reduced
binding to avian receptors may correspond to a phenotype inter-
mediate in adaptation to more human-like characteristics. For
example, reduced α2-3-sialyl binding may beneﬁt efﬁcient viral
replication in humans by evading the inhibitory effects of α2-3-
sialyl glycans present in mucins in the human respiratory tract
(Manz et al., 2010). Thus, adaptive evolution of avian inﬂuenza
H5N1 viruses to efﬁcient binding of human receptors may be a
more complex multistep process (Chen et al., 2012). In this respect,
it should be noted that the recently reported passage studies in
ferrets, which showed that only a limited number of amino acid
changes is needed for air-borne transmission of H5N1 viruses,
used genetically engineered virus already containing two changes
that confer increased α2-6-sialyl binding (Imai et al., 2012; Herfst
et al., 2012), changes which did not emerge during passage in
ferrets of wild-type viruses. Transmission of the VN1194 mutant
was associated with a substantial reduction in afﬁnity for avian
α2-3-sialyl receptors and only a slight increase in afﬁnity for
human α2-6-sialyl receptors, and Xiong et al. (2013) emphasized
the importance of the ratio of preference for the two receptors in
determining the biological characteristics. Of note, in addition to
the changes in HA that alter receptor speciﬁcity, the three human
H5N1 viruses investigated (A/Vietnam/CL1/2004, A/Vietnam/
CL105/2005, and A/Vietnam/CL2009C/2005) possessed a Glu627Lys
change in PB2 (de Jong et al., 2006), the role of which in
mammalian adaptation of highly pathogenic avian inﬂuenza viruses
is well established (Hatta et al., 2001; Le et al., 2009; Shinya et al.,
2004; Steel et al., 2009). The detection of multiple adaptive changes
in these viruses during human H5N1 infections emphasizes the
need for intensive monitoring and vigilance with respect to the
continuing threat of H5N1 inﬂuenza for global health.
Material and methods
Ethics statement
Specimens from patients with H5N1, H1N1 and H3N2 inﬂuenza
came from existing collections from three observational studies on
(a) human H5N1 inﬂuenza (de Jong et al., 2005b, 2006); (b) the
viral etiology of respiratory tract infections (Do et al., 2011) and
(c) on the etiology of viral CNS infections (Le et al., 2010; de Jong
et al., 2005a). These studies were approved by the institutional
review board of the Hospital for Tropical Diseases, Ho Chi Minh
City, and the Oxford Tropical Research Ethical Committee. Infor-
med consent was obtained from all participating patients or their
parents or legal guardians.
The poultry specimens also came from existing collections,
collected as part of surveillance activities.
Viruses
Human H5N1 viruses were isolated from nose or throat swabs
collected from 11 patients with RT-PCR conﬁrmed H5N1 infection.
These patients were admitted to the Hospital for Tropical Diseases
in Ho Chi Minh City, Vietnam, during H5N1 outbreaks in early
2004 and 2005 (Tran et al., 2004; Beigel et al., 2005; de Jong et al.,
2005b, 2006). In addition, 17 avian inﬂuenza viruses (HPAI H5N1,
LPAI H4N6 and H6N1) were isolated from tracheal or cloacal swabs
collected from poultry (chickens and ducks) in southern Vietnam
in the winter of 2006. Ten seasonal human inﬂuenza viruses
(6H1N1, 4H3N2) served as controls in hemagglutination assays
and were isolated from respiratory specimens collected as part of
surveillance studies from patients with acute respiratory illness
admitted to the Hospital for Tropical Diseases. All swabs were
collected in Viral Transport Medium (MEM with Hanks' salts,
supplemented with 0.5% gelatin and antibiotics [Sigma-Aldrich])
and stored at 80 1C until further analyses. Initial virus isolation
was performed in MDCK cells. Isolated viruses were identiﬁed and
subtyped by means of hemagglutination-inhibition assays and
subtype-speciﬁc RT-PCRs as described before (Beigel et al., 2005).
All inﬂuenza viruses used for the experiments belonged to the
same geographical region. H5N1 viruses were all isolated in
biosafety level three culture facilities at OUCRU, Vietnam.
Cells
Madin Darby Canine Kidney (MDCK) cells were cultured in
MEM [Eagle's Minimal Essential Medium (Gibco, Invitrogen, USA)
containing L-Glutamine and antibiotics]. MDCK-SIAT1 cells, geneti-
cally modiﬁed to overexpress Neu5Ac2-6 Gal-terminated oligosac-
charides, were cultured in MEM containing 1 mg/ml of G-418
antibiotic as previously described (Matrosovich et al., 2003).
Egg passages
200 μl of virus sample were inoculated into the allantoic cavity
of 11-day old embryonated hen eggs. After two days of incubation
at 35 1C the allantoic ﬂuid was extracted and virus titrated by
hemagglutination assay.
Preparation of recombinant viruses
Recombinant H5N1 viruses, in which the HA gene of A/Puerto
Rico/8/34 (PR8) was replaced by various mutant H5 genes, were
generated by reverse genetics as previously described (Hoffmann
et al., 2000); the other seven genes were from PR8. A cDNA clone
of the HA gene of A/Vietnam/1194/2004 (H5N1), in which the
multi-basic cleavage site has been replaced by a single arginine
cleavage site (QRERRRKKR to QRETR change), was a gift from
Dr. Y. Kawaoka, University of Wisconsin (Yamada et al., 2006).
Mutations were introduced into cDNA clones by using a Quik-
Change site-directed mutagenesis kit (Stratagene, La Jolla, CA)
according to the manufacturer's protocol. Two sets of mutant
viruses were constructed (Table 3) – one set with single substitu-
tions relative to the HA sequence of A/Vietnam/1194/2004
[rVN1194(Ala134Val) and rVN1194(Glu186Asp)]; the other set
with additional substitutions such that the HA sequences corre-
spond (apart from the difference in cleavage site) to the actual
sequences of the MDCK cell isolates [rVNCL105(Ala134Val) and
rVNCL01(Glu186Asp)]. For rVNCL01(Glu186Asp) an additional sub-
stitution was introduced at residue 175 relative to rVN1194
(Glu186Asp). For rVNCL105(Ala134Val) and the 151Phe variant
the whole HA cDNA was chemically synthesized (GeneArt™ Gene
Synthesis, Invitrogen) and cloned into the vector pHW2000
(Hoffmann et al., 2000). Eight plasmids, each containing one of
the 8 virus genes, were co-transfected into co-cultured 293T and
MDCK cells. After 3–5 days, viruses in the supernatants were
recovered by passage in MDCK cells and then grown in the
allantoic cavity of 10 day old embryonated hen eggs. The candidate
vaccine virus NIBRG14 (Wood and Robertson, 2004), which pos-
sesses the HA, with modiﬁed cleavage site, (consensus sequence,
Table 3) and neuraminidase (NA) from A/Viet Nam/1194/2004 and
six internal genes of PR8, was obtained from the National Institute
for Biological Standards and Control. The reassortant human H3N2
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virus X31 contains the HA and NA of A/Aichi/2/68 and the six
internal genes of PR8. Recombinant virus R1 containing the HA
and NA of A/Hong Kong/1/68 (H3N2) and remaining genes of
A/WSN/33 (H1N1) was generated by reverse genetics (Matrosovich
et al., 2007). Viruses were puriﬁed by sucrose gradient sedimenta-
tion (Skehel and Schild, 1971). The HA genes of all recombinant
viruses were sequenced before and after egg growth to conﬁrm
their identities.
Construction of recombinant vaccinia virus and puriﬁcation
of expressed HA
The HA gene encoding the Ile151Phe mutant HA was incorpo-
rated into the pRB21 plasmid and recombined with the helper
vaccinia virus vRB12 in CV-1 cells to generate a recombinant
vaccinia virus encoding the HA, using the system developed by
Blasco and Moss (1995). Membrane preparations from recombi-
nant vaccinia virus-infected CV-1 cells were solubilized in 1%
dimethyldodecylamine-N-oxide (LDAO) and the HA puriﬁed by
sucrose gradient centrifugation and ion-exchange chromatogra-
phy, followed by bromelain digestion, as previously described
(Chen et al., 1998).
Hemagglutination assays
Hemagglutination assays were performed in parallel using two
types of red blood cells (RBCs) with differing receptor distribu-
tions: horse RBCs which almost exclusively express α2-3-sialyl
receptors, and guinea pig RBCs which express both α2-3-sialyl and
α2-6-sialyl receptors (Ito et al., 1997a, 1997b; Medeiros et al.,
2001). Two-fold dilutions of the virus in phosphate-buffered saline
(PBS) at pH 7.2 were mixed in triplicate with equal volumes of
guinea pig or horse RBCs diluted in PBS (0.75% and 0.8%, respec-
tively). After 1 h at room temperature the plates were checked for
the presence or absence of RBC agglutination and HA titers were
determined as the last dilution were detectable hemagglutination
was observed.
RNA extraction and cDNA synthesis
Viral RNA from clinical specimens, cell culture supernatants or
allantoic ﬂuids was extracted using a spin-based commercial kit
(QIAamps; Qiagen, Germany). The ﬁnal RNA sample was eluted
with 250 μl of AVE buffer and stored at 80 1C. The synthesis of
complementary DNA from RNA samples was performed using
UNI12 primer in a double-step Reverse-Transcription.
PCR and sequence analysis
A 1027-bp fragment of the HA1 domain of the H5 gene was
ampliﬁed using the primers: 5′-CGACAGAGCAGGTTGACACAATA-3′
and 5′-GTACCCATACCAACCATCTACCATTC-3′. The generated ampli-
cons were puriﬁed using a QIAquicks PCR spin kit (Qiagen,
Germany) and were sequenced with the use of a BigDye Termi-
nator Cycle Sequencing Kit version 3.1 (Applied Biosystems), using
internal sequence primers. Primers used for sequencing are avail-
able upon request. Sequenced fragments were assembled and
edited with the use of BioLign version 4.0 (Tom Hall, North
Carolina State University). Alignments and residue analyses were
performed in BioEdit version 7.0. The sequences of viruses origin-
ally isolated in MDCK cells were compared pair wise with those
obtained after ﬁve passages in the allantois of embryonated
hen eggs.
Pyrosequencing
Biotinylated primers for ampliﬁcation of HA fragments encom-
passing mutations of interest (Asp186Glu, Val134Ala and
Ile151Phe) and sequencing primers were generated using PSQ
assay design software (version 1.0.6, Biotage, Sweden). Primer
sequences are available upon request. The HA fragments were
ampliﬁed in separate PCR reactions in a total volume of 25 μl each,
containing 400 mM dNTPs, 1.5 mM MgCL2 (Qiagen, Germany),
400 mM of each forward and reverse primer, 1 unit of HotStar
Taq (Qiagen, Germany), and 5 ml of cDNA. Biotinylated PCR
products were mixed with streptavidin-coated sepharose beads
(Amersham Biosciences) followed by treatment with a denatura-
tion solution (Pyro Gold Reagents kit, Biotage) to remove non-
biotinylated strands. They were then suspended in annealing
buffer (Pyro Gold Reagents kit, Biotage) containing each sequen-
cing primer and subjected to pyrosequencing on a PyroMark™ID
instrument according to the manufacturer's instructions (Biotage,
Sweden). All resulting pyrograms were automatically analyzed by
the PyroMark™ID software version 1.0.5. The limit of detection of
viral subpopulations was determined at 10%. To test the depth of
coverage, Sanger sequencing was performed on greater than 100
randomly selected bacterial clones. The results revealed a depth of
close to 1 in 100.
Receptor-binding assay using sialylglycopolymers
Synthetic biotinylated sialylglycopolymers (SGPs), 3SLN-PAA
and 6SLN-PAA carrying the Neu5Acα2–3Galβ1–4GlcNAc and
Neu5Acα2–6Galβ1–4GlcNAc moieties, respectively, were kindly
provided by Nicolai Bovin at the Shemyakin and Ovchinnikov
Institute of Bioorganic Chemistry, Moscow, Russia. The SGPs
contained 20 mol% of the sialyloligosaccharide and 5 mol% of
biotin attached to either a 30 kDa or 1 MDa polyacrylamide carrier
(Bovin et al., 1993). The binding of SGPs to immobilized viruses
using a solid-phase assay was determined as previously described
(Matrosovich et al., 2000; Matrosovich and Gambaryan, 2012).
Biolayer interferometry analysis
Quantitative virus binding experiments were done by biolayer
interferometry (BLI) on an Octet RED instrument from Pall For-
teBio (Menlo Park, CA, USA), as described (Lin et al., 2012). Brieﬂy,
biotinylated 30 kDa sialylglycopolymers 3SLN-PAA and 6SLN-PAA,
from Lectinity (Moscow, Russia), were loaded onto streptavidin
biosensors (ForteBio) at 0.01–0.5 μg/ml for 5 min in 10 mM HEPES,
pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% Tween-20. Following a
buffer wash, biosensors were incubated with virus solution
(100 pM/2000 HA titer) for 30 min, during which time the
association was measured. Experiments were performed at 25 1C
and sample plates were agitated at 1000 RPM. Solutions of viruses
and all solutions in which biosensors were incubated with virus
contained 10 μM oseltamivir carboxylate (Roche) and 10 μM
zanamivir (GlaxoSmithKline) to inhibit the viral neuraminidase.
Responses at equilibrium were normalized with respect to the
maximum response for virus binding and plotted as a function of
the amount of sugar immobilized on the biosensor, calculated
from the response amplitude during the sugar loading step.
Experiments were performed in at least duplicate and the data
were pooled for ﬁtting. Relative afﬁnities were estimated from
apparent Kds calculated from the fractional occupancy.
Carbohydrate microarray analyses
Puriﬁed viruses were inactivated by treatment with β-pro-
piolactone (0.166% v/v) for 40 min at 33 1C. Viruses were pelleted
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by centrifugation at 100,000g for 30 min and resuspended in
0.01 M phosphate buffered saline pH 7.4 (PBS) containing 0.05%
sodium azide. The β-propiolactone has been shown previously not
to affect the binding proﬁle of viruses in microarray analyses
(Childs et al., 2009), and did not affect the hemagglutination titers
of the H5N1 viruses using turkey, guinea pig or horse erythrocytes
(not shown).
The virus concentrations were adjusted so that the stock
preparations had equal HA glycoprotein content. This was deter-
mined for the various puriﬁed virus preparations by densitometric
measurement of the HA band in Coomassie blue stained SDS
polyacrylamide gels run under non-reducing conditions. A virus
standard, where the total viral protein content had been deter-
mined using a BCA protein assay kit (Thermo Fisher Scientiﬁc,
Cramlington, UK), was included on the gel and virus concentra-
tions are expressed as mg total virus protein per ml.
Carbohydrate microarray analyses were performed, essentially
as described (Childs et al., 2009), using a new version of oligo-
saccharide microarrays (Glycosciences Array Set 40-41) containing
six neutral and 119 sialylated, lipid-linked oligosaccharide probes
(Supplementary Table S2). In brief, the viruses were suspended in
20 mM HEPES buffer pH 7.2 containing 150 mM NaCl, 5 mM CaCl2,
0.15 mM zanamivir (a gift from GlaxoSmithKline) (HBS-Ca2þ/Z),
and 0.2% (w/v) bovine serum albumin (BSA, fatty acid and globulin
free, Sigma A0281). The solution for blocking non-speciﬁc binding
and as a diluent for reagents in the analyses was HBS-Ca2þ/Z
containing 2% (w/v) BSA. In the present investigations H5N1
viruses were analyzed at 1 mg HA protein/ml and X31 virus at
0.6 mg HA protein/ml. Binding of the H5N1 viruses was detected
with a hyperimmune ferret anti-NIBRG14 serum, and of X31
with a rabbit antiserum to this virus, at 1:150 dilution, followed
by biotin-conjugated protein A (10 mg/ml) and Alexa Fluor 647-
conjugated Streptavidin A (1 mg/ml). In the absence of viruses, no
signiﬁcant signals were given by the antisera. The results pre-
sented in Fig. 3 are representative of at least two independent
analyses with each virus.
Crystallographic methods
Wild type and mutant HAs were prepared by bromelain
digestion of puriﬁed viruses or HA puriﬁed from membrane
preparations of vaccinia virus-infected cells, as previously
described (Chen et al., 1998; Ha et al., 2002). Crystallization
conditions were as reported for NIBRG14 BHA (Yamada et al.,
2006) and crystals with bound receptor analogs were prepared
by soaking the BHA crystals overnight in either 4 mM LSTa
(NeuAcα2–3Galβ1–3GlcNAcβ1–3Galβ1–4Glc) or 4 mM LSTc
(NeuAcα2–6Galβ1–4GlcNAcβ1–3Galβ1–4Glc) in cryo buffer. All
of the data were collected at the Diamond Light Source at 100 K
and were integrated using Denzo and scaled with Scalepack.
Standard reﬁnement, with Refmac and PHENIX, and manual model
building with Coot was performed on all of the structures. The
reﬁnement statistics and the relative real space correlation coefﬁ-
cients of the ligand are given in Supplementary Tables S3, S4, S5,
S6 and S7. The ﬁgures (panels in Fig. 4) were created with Pymol.
Additional information
Accession codes
Coordinates and structure factors were deposited in the PDB
database under accession codes: 3ZP0 (rVN1194 H5 HA with LSTa),
3ZP1 (rVN1194 H5 HA with LSTc), 3ZP2 (rVN1194(Ala138Val) H5
HA mutant with LSTa), 3ZP3 (rVN1194(Ala138Val) H5 HA mutant
with LSTc), 3ZPb (rVN1194(Glu190Asp) H5 HA mutant with LSTa),
3ZP6 (rVN1194(Glu190Asp) H5 HA mutant with LSTc), and 3ZPa
(rVN1194(Ile155Phe) H5 HA mutant). Note: The amino acid resi-
due numbering of the deposited structures is based on the H3
sequence (e.g. 138Val, 190Asp and 155Phe) and not on the H5
sequence (e.g. 134Val, 186Asp and 151Phe) selected here.
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